Seftor E - Search Results

1

Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V. Bittner M, et al. Among authors: seftor e. Nature. 2000 Aug 3;406(6795):536-40. doi: 10.1038/35020115. Nature. 2000. PMID: 10952317 Free article.

2

Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice.

Ray RB, Steele R, Seftor E, Hendrix M. Ray RB, et al. Among authors: seftor e. Cancer Res. 1995 Sep 1;55(17):3747-51. Cancer Res. 1995. PMID: 7641187

3

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R. Zou Z, et al. Among authors: seftor e. Science. 1994 Jan 28;263(5146):526-9. doi: 10.1126/science.8290962. Science. 1994. PMID: 8290962

4

Molecular determinants of human uveal melanoma invasion and metastasis.

Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, Folberg R, Hendrix MJ. Seftor EA, et al. Clin Exp Metastasis. 2002;19(3):233-46. doi: 10.1023/a:1015591624171. Clin Exp Metastasis. 2002. PMID: 12067204

5

A molecular role for lysyl oxidase in breast cancer invasion.

Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ. Kirschmann DA, et al. Cancer Res. 2002 Aug 1;62(15):4478-83. Cancer Res. 2002. PMID: 12154058

6

The paradoxical expression of maspin in ovarian carcinoma.

Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA, Hendrix MJ. Sood AK, et al. Among authors: seftor ea. Clin Cancer Res. 2002 Sep;8(9):2924-32. Clin Cancer Res. 2002. PMID: 12231537

7

Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry.

Seftor EA, Meltzer PS, Schatteman GC, Gruman LM, Hess AR, Kirschmann DA, Seftor RE, Hendrix MJ. Seftor EA, et al. Among authors: seftor re. Crit Rev Oncol Hematol. 2002 Oct;44(1):17-27. doi: 10.1016/s1040-8428(01)00199-8. Crit Rev Oncol Hematol. 2002. PMID: 12398997 Review.

8

Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.

Seftor RE, Seftor EA, Kirschmann DA, Hendrix MJ. Seftor RE, et al. Among authors: seftor ea. Mol Cancer Ther. 2002 Nov;1(13):1173-9. Mol Cancer Ther. 2002. PMID: 12479698

9

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.

Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Hendrix MJ, et al. Among authors: seftor re, seftor ea. Nat Rev Cancer. 2003 Jun;3(6):411-21. doi: 10.1038/nrc1092. Nat Rev Cancer. 2003. PMID: 12778131 Review.

10

Molecular plasticity of human melanoma cells.

Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Hendrix MJ, et al. Among authors: seftor re, seftor ea. Oncogene. 2003 May 19;22(20):3070-5. doi: 10.1038/sj.onc.1206447. Oncogene. 2003. PMID: 12789282 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page